CDK4 and esophageal squamous cell carcinoma: Similarly, PD‐0332991, a potent inhibitor of cyclin D1‐cyclin‐dependent kinase 4/6 (CDK4/6), has been shown curtail cell proliferation, induce apoptosis and senescence, and suppress migration, invasion, and metastasis in ESCC.